V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008270 | 310005439 | null | 63.8 | Palliative (P) | null | 2015-07-25 | Cytarabine HD + Methotrexate HD | 02 | N | 310001682 | METHOTREXATE HIGH DOSE |
| 310008271 | 310005439 | 1.77 | 25.8 | Disease modification (D) | 2018-07-11 | 2018-07-11 | Capecitabine + Oxaliplatin 21day | Y | N | 310001682 | ECX |
| 310008272 | 310005440 | 1.6 | 50.7 | Palliative (P) | 2013-12-06 | 2013-12-06 | Azacitidine | N | null | 310001938 | AZACITIDINE |
| 310008273 | 310005444 | null | 109 | Curative (C) | 2014-06-12 | 2014-07-22 | CISPLATIN + FLUOROURACIL | N | null | 310002265 | LENALIDOMIDE |
| 310008274 | 310005445 | 1.62 | 60 | Palliative (P) | 2017-09-13 | 2017-10-12 | DABRAFENIB | N | N | 310002273 | ICON TRIAL |
| 310008275 | 310005446 | 1.69 | 66 | Curative (C) | 2015-03-29 | 2015-03-29 | Lenalidomide Cycle 26 onwards (PAS) | N | N | 310002273 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310008276 | 310008401 | null | 75.1 | Palliative (P) | 2017-07-21 | 2017-09-14 | DOXORUBICIN | N | null | 310002332 | EURO-EWING |
| 310008277 | 310008401 | 1.77 | 7.3 | Palliative (P) | 2018-12-28 | 2019-01-10 | Methotrexate High Dose (3g/m2) | 02 | N | 310002332 | PEG INTERFERON |
| 310008278 | 310008401 | 1.62 | 47.6 | Palliative (P) | 2015-08-29 | 2015-09-06 | CISPLATIN + FLUOROURACIL | 02 | N | 310002332 | AZACITIDINE |
| 310008279 | 310005451 | 1.69 | 64 | Curative (C) | 2015-05-17 | 2015-05-19 | Doxorubicin 75mg/m2 | 2 | N | 310002565 | IVA |
| 310008280 | 310005452 | null | null | Palliative (P) | null | 2014-09-27 | Capecitabine | N | N | 310002632 | ICON TRIAL |
| 310008281 | 310005454 | 1.79 | null | Adjuvant (A) | 2015-06-20 | 2015-06-21 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 310002632 | TRASTUZUMAB |
| 310008282 | 310005454 | 1.53 | 56.4 | Curative (C) | 2017-04-21 | 2017-04-21 | Bendamustine + prednisolone | N | N | 310002632 | TRASTUZUMAB |
| 310008283 | 310005455 | 1.7 | 63.8 | Palliative (P) | 2016-12-16 | 2017-01-19 | ICE-R | 2 | N | 310003095 | VINBLASTINE |
| 310008284 | 310005456 | 1.79 | 104.3 | Palliative (P) | null | 2016-09-18 | Methotrexate 25-50mg/m2 iv 7day | null | N | 310003110 | TRABECTEDIN |
| 310008285 | 310005457 | null | null | Palliative (P) | 2019-10-28 | 2019-11-11 | INTERFERON | 2 | N | 310003110 | CETUXIMAB |
| 310008286 | 310005457 | 1.46 | 62 | Palliative (P) | 2017-12-18 | 2017-12-18 | Bevacizumab + CARBOPLATIN + GEMCITABINE | N | N | 310003110 | ICON8B TRIAL |
| 310008287 | 310005459 | 1.73 | 56 | Palliative (P) | 2017-11-22 | 2017-11-22 | CAPECITABINE + CARBOPLATIN | N | N | 310003257 | IMATINIB |
| 310008288 | 310005460 | 1.64 | null | Palliative (P) | 2014-06-09 | 2014-06-10 | FLUOROURACIL + OXALIPLATIN | null | null | 310003259 | RUXOLITINIB |
| 310008289 | 310005462 | 1.72 | 106 | Neo-adjuvant (N) | 2014-10-02 | 2014-10-17 | Lenalidomide Cycle 26 onwards (PAS) | 2 | N | 310003401 | CYTARABINE |
| 310008290 | 310005462 | 1.82 | 75.1 | Curative (C) | 2017-09-23 | 2017-10-11 | Oxaliplatin + Modified de Gramont | 2 | N | 310003401 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 310008291 | 310005462 | 1.66 | 58.6 | Curative (C) | 2014-10-13 | 2017-05-18 | Cisplatin + Topotecan | N | N | 310003401 | DOXORUBICIN + OLARATUMAB |
| 310008292 | 310005462 | 1.56 | 15.4 | Curative (C) | 2018-04-17 | 2018-04-30 | UKALL14- Ph 2 Induction | N | N | 310003401 | CHLORAMBUCIL |
| 310008293 | 310011848 | 1.81 | 70.8 | Curative (C) | 2018-12-30 | 2019-01-10 | ICE | N | N | 310003549 | CISPLATIN + FLUOROURACIL |
| 310008294 | 310008409 | 1.71 | 78 | Curative (C) | null | 2017-10-16 | ETOPOSIDE + MELPHALAN | N | N | 310003601 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310008295 | 310005464 | 1.85 | null | Curative (C) | 2015-06-28 | 2015-07-26 | R GCVP | 2 | N | 310003649 | CYCLO + DOXORUBICIN + VINCRISTINE |
| 310008296 | 310005466 | 1.84 | 69.6 | Neo-adjuvant (N) | 2017-02-03 | 2017-03-06 | CVP R | N | N | 310003672 | THALIDOMIDE |
| 310008297 | 310005469 | null | 48.2 | Palliative (P) | 2014-04-01 | 2014-04-01 | Olaparib | N | N | 310003701 | CAV |
| 310008298 | 310005471 | 0 | 63.85 | Curative (C) | 2016-10-07 | 2017-03-06 | Trabectedin | null | null | 310003732 | MVAC |
| 310008299 | 310005472 | 0 | 64.3 | Adjuvant (A) | 2015-10-18 | 2015-10-19 | CVP | N | N | 310003732 | DACARBAZINE |
| 310008300 | 310005473 | 1.63 | 79.4 | Palliative (P) | null | 2018-01-25 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | N | 310003753 | VINBLASTINE |
| 310008301 | 310005477 | 1.26 | null | Palliative (P) | 2014-01-08 | 2014-01-08 | Imatinib 400mg | N | null | 310003761 | RUXOLITINIB |
| 310008302 | 310005477 | 1.74 | 79.8 | Curative (C) | 2014-08-06 | 2015-06-30 | Enzalutamide | N | N | 310003761 | CETUXIMAB |
| 310008303 | 310008417 | 1.48 | 44.6 | Curative (C) | 2017-04-10 | 2017-05-29 | DABRAFENIB | N | N | 310003812 | TEMOZOLOMIDE |
| 310008304 | 310008417 | null | null | Palliative (P) | 2015-08-03 | 2015-08-17 | Capecitabine | 02 | N | 310003812 | ADE |
| 310008305 | 310005482 | 1.82 | 66 | Palliative (P) | 2014-04-13 | 2014-05-06 | Atezolizumab | Y | N | 310004066 | CETUXIMAB |
| 310008306 | 310005483 | 1.77 | 74.3 | Neo-adjuvant (N) | 2016-08-25 | 2016-09-20 | Vemurafenib | N | N | 310004066 | CETUXIMAB |
| 310008307 | 310005483 | 1.8 | 79.4 | Palliative (P) | 2015-04-30 | 2018-06-29 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 310004066 | IVA |
| 310008308 | 310011330 | 1.62 | 83 | Adjuvant (A) | 2016-08-20 | 2016-08-20 | Pentostatin | N | N | 310004863 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 310008309 | 310011330 | 0 | 60.2 | Palliative (P) | null | 2017-12-20 | DABRAFENIB + TRAMETINIB | N | N | 310004863 | ICON8B TRIAL |
| 310008310 | 310011330 | 1.7 | 112.3 | Curative (C) | 2015-05-09 | 2015-05-16 | Cisplatin + Pemetrexed | N | null | 310004863 | OXALIPLATIN + MDG |
| 310008311 | 310005484 | 1.66 | 53.7 | Palliative (P) | 2017-07-04 | 2017-08-20 | CISPLATIN + FLUOROURACIL | N | N | 310005210 | DOXORUBICIN |
| 310008312 | 310008421 | 1.83 | null | Palliative (P) | 2017-02-12 | 2017-02-16 | IMATINIB | N | N | 310005586 | MITOMYCIN INTRAVESICULAR |
| 310008313 | 310009989 | 1.67 | 84.7 | Curative (C) | 2015-09-18 | 2015-09-20 | CVD | 02 | N | 310005644 | BENDAMUSTINE |
| 310008314 | 310009989 | 1.6 | 54.1 | Curative (C) | 2014-09-20 | 2014-11-01 | ICON8 TRIAL | 02 | null | 310005644 | DACARBAZINE |
| 310008315 | 310011331 | 1.64 | 50.8 | Palliative (P) | 2018-09-14 | 2018-10-15 | LANREOTIDE | 2 | N | 310005670 | CEV |
| 310008316 | 310005486 | 1.6 | 0 | null | 2013-10-20 | 2013-10-20 | Bendamustine + prednisolone | N | N | 310005975 | CETUXIMAB |
| 310008317 | 310005490 | 1.33 | 92.1 | null | 2017-11-30 | 2018-01-01 | Dacarbazine | 02 | N | 310005975 | TEMOZOLOMIDE |
| 310008318 | 310005490 | 1.72 | null | Curative (C) | 2014-03-22 | 2014-12-06 | Methotrexate High Dose (3g/m2) | N | N | 310005975 | CETUXIMAB + CISPLATIN + FU |
| 310008319 | 310005491 | 1.64 | 79 | Curative (C) | 2016-12-05 | 2016-12-09 | Methotrexate High Dose (3g/m2) | N | N | 310006343 | CARBOPLATIN + PEMETREXED |